Clinical Trial Update: A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States [Phase 4]

View source ↗

Summary

Results from a Phase 4 study evaluating strategies for delivering cabotegravir for HIV PrEP across low- and high-volume sites in the United States have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2025-12-15